Han Jianyu,Chang Xiaofeng,Qin Hong,et al.Analysis of curative effect of BEP chemotherapy in endodermal sinus tumor of vagina[J].Journal of Clinical Pediatric Surgery,,20():557-561,575.[doi:10.12260/lcxewkzz.2021.06.010]
Analysis of curative effect of BEP chemotherapy in endodermal sinus tumor of vagina
- Keywords:
- Vaginal Neoplasms; Neoplasms; Germ Cell and Embryonal; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Child
- CLC:
- R737.34;R979.1;R730.265.82
- Abstract:
- Objective To explore the therapeutic efficacy and prognosis of BEP chemotherapy in children with vaginal endodermal sinus tumor (EST).Methods A retrospective review was conducted for medical records of children with vaginal EST from 2008 to 2020.The clinical manifestations,age of onset,tumor size and distant metastasis were recorded.All cases were diagnosed by preoperative pathological examinations.Follow-up methods included ultrasonography,computed tomography (CT) and serum level of alpha fetoprotein (AFP).The standard BEP chemotherapeutic regimen of bleomycin,etoposide and cisplatin was adopted.Prognostic evaluations were based upon the WHO criteria of general solid tumor efficacy:complete remission (CR),partial remission (PR),disease stability (SD),disease progression (PD).Results Twelve children were recruited with a median age of 14.5(9-21) years.The average tumor size was 4.1 cm.One child had iliac fossa lymph node metastasis.After an average of 4 chemotherapeutic courses,they achieved CR (n=7,58.3%) and PR (n=5,41.7%).Among 5 PR children,3 cases were operated for CR and postoperative pathology confirmed necrotic tumor cells.Two children turning down surgery received more cycles of BEP chemotherapy.One case achieved CR at Month 7 while another with lymph node metastasis maintained in PR.The elevated AFP returned to a normal level after an average of 2.8 cycles of chemotherapy.During a mean follow-up period of 101 months,there was no recurrence.Conclusion Vaginal EST may yield an excellent outcome through a standardized chemotherapy.As a first-line treatment protocol,BEP has an obvious efficacy.Most children can achieve CR and there is no recurrence during long-term follow-ups.For PR children,surgery can effectively remove residual nodules and prevent recurrence.
References:
1 Saltzman AF,Gills JRR,Leblanc DM,et al.Multimodal management of a pediatric cervical yolk sac tumor[J].Urology,2015,85(5):1186-1189.DOI:10.1016/j.urology.2015.01.034.
2 Watanabe N,Okita H,Matsuoka K,et al.Vaginal yolk sac (endodermal sinus) tumors in infancy presenting persistent vaginal bleeding[J].J Obstet Gynaecol Res,2010,36(1):213-216.DOI:10.1111/j.1447-0756.2009.01083.x.
3 Rajagopal R,Ariffin H,Krishnan S,et al.pediatric vaginal yolk sac tumor:reappraisal of treatment strategy in a rare tumor at a unique location[J].J Pediatr Hematol Oncol,2015,37(5):391-395.DOI:10.1097/MPH.0000000000000344.
4 Miller AB,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47(1):207-214.DOI:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.
5 Lacy J,Capra M,Allen L.Endodermal sinus tumor of the infant vagina treated exclusively with chemotherapy[J].J Pediatr Hematol Oncol,2006,28(11):768-771.DOI:10.1097/01.mph.0000243661.56432.ec.
6 De La Motte Rouge T,Pautier P,Duvillard P,et al.Survival and reproductive function of 52 women treated with surgery and bleomycin,etoposide,cisplatin (BEP) chemotherapy for ovarian yolk sac tumor[J].Annals of Oncology,2008,19(8):1435-1441.DOI:10.1093/annonc/mdn162.
7 Talerman A,Van der Pompe WB,Haije WG,et al.Alpha-foetoprotein and carcinoembryonic antigen in germ cell neoplasms[J].Br J Cancer,1977,35(3):288-291.DOI:10.1038/bjc.1977.41.
8 Young RH,Scully RE.Endodermal sinus tumor of the vagina:a report of nine cases and review of the literature[J].Gynecol Oncol,1984,18(3):380-392.DOI:10.1016/0090-8258(84)90050-7.
9 Tao T,Yang JX,Cao DY,et al.Conservative treatment and long-term follow up of endodermal sinus tumor of the vagina[J].Gynecol Oncol,2012,125(2):358-361.DOI:10.1016/j.ygyno.2011.12.430.
10 黄薇,邹放军.婴幼儿阴道内胚窦瘤1例[J].临床小儿外科杂志,2012,11(5):400.DOI:10.3969/j.issn.1671-6353.2012.05.032. Huang W,Zhou FJ.One case report of infantile vaginal endodermal sinus tumor[J].J Clin Ped Sur,2012,11(5):400.DOI:10.3969/j.issn.1671-6353.2012.05.032.
11 Shalet SM,Beardwell CG,Jones PH,et al.Ovarian failure following abdominal irradiation in childhood[J].Br J Cancer,1976,33(6):655-658.DOI:10.1038/bjc.1976.103.
12 el-Mahdi AM,Marks R Jr,Thornton WN,et al.Sequelae of pelvic irradiation in infancy:25-year followup[J].Radiology,1974,110(3):665-666.DOI:10.1148/110.3.665.
13 Beller FK,Nienhaus H,Gizycki BSV,et al.Endodermal germ cell carcinoma (endodermal sinus tumor) of the vagina in infant girls[J].J Cancer Res Clin Onco,1979,94(3):295-306.DOI:10.1007/BF00419289.
14 Copeland LJ,Sneige N,Ordonez NG,et al.Endodermal sinus tumor of the vagina and cervix[J].Cancer,1985,55(11):2558-2565.DOI:10.1002/1097-0142(19850601)55:11<2558::aid-cncr2820551107>3.0.co;2-j.
15 Hwang EH,Han SJ,Lee MK,et al.Clinical experience with conservative surgery for vaginal endodermal sinus tumor[J].J Pediatr Surg,1996,31(2):219-222.DOI:10.1016/s0022-3468(96)90000-7.
16 Rescorla F,Billmire D,Vinocur C,et al.The effect of neoadjuvant chemotherapy and surgery in children with malignant germ cell tumors of the genital region:a pediatric intergroup trial[J].J Pediatr Surg,2003,38(6):910-912.DOI:10.1016/s0022-3468(03)00121-0.
17 Handel LN,Scott SM,Giller RH,et al.New perspectives on therapy for vaginal endodermal sinus tumors[J].J Urol,2002,168(2):687-690.DOI:10.1016/s0022-5347(05)64724-6.
18 滕腾,刘江斌,吕志宝.化疗联合手术治疗小儿阴道内胚窦瘤的疗效分析[J].临床小儿外科杂志,2020,19(8):717-720.DOI:10.3969/j.issn.1671-6353.2020.08.011. Teng T,Liu JB,Lv ZB.Treatment of vaginal endodermal sinus tumor with chemotherapy and surgery in infants[J].J Clin Ped Sur,2020,19(8):717-720.DOI:10.3969/j.issn.1671-6353.2020.08.011.
19 Tang QL,Jiang XF,Yuan XP,et al.Prognosis of eight Chinese cases of primary vaginal yolk sac tumor with a review of the literature[J].Asian Pac J Cancer Prev,2014,15(21):9395-9404.DOI:10.7314/apjcp.2014.15.21.9395.
Memo
收稿日期:2020-05-25;。
通讯作者:王焕民,Email:wanghuanmin@bch.com.cn